ISHARES U.S. PHARMACEUTICALS ETF

$IHE
← All companies Sign in to track
Institutional coverage

188 13F filers hold $IHE.

13F holders
188
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

2 holders · Q1 2026

Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.

01
CV Advisors LLC
0.01% held
α +29.1pts
02
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
0.00% held
α +27.5pts

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 188 · Source: 13F-HR
01
Citizens Financial Group INC
0.08% of portfolio
2,767,359 sh
02
USAdvisors Wealth Management, LLC
0.74% of portfolio
2,000,175 sh
03
Proficio Capital Partners LLC
0.20% of portfolio
286,543 sh
04
Blue Edge Capital, LLC
3.14% of portfolio
259,154 sh
05
Tikehau Investment Management
1.16% of portfolio
237,384 sh
06
Systelligence, LLC
4.35% of portfolio
202,612 sh
07
Taconic Capital Advisors LP
—
170,188 sh
08
PrairieView Partners, LLC
0.98% of portfolio
152,688 sh
09
FengHe Fund Management Pte. Ltd.
0.01% of portfolio
109,471 sh
10
Sheaff Brock Investment Advisors, LLC
—
109,054 sh
See all 188 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $IHE in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $IHE in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 12:57 UTC.